S2 R1
| Resources - ICH Guidances |
The ICH has approved a revision to its genotoxicity testing and data interpretation guidelines that it says will improve risk assessment and reduce the number of animals used during preclinical development.
| Next > |
|---|
Most Recent Guidances (All Agencies)
- Factors Influencing the Classification of Products at the Device-Drug Interface
- FDA proposes draft guidelines intended to improve the representation of women in medical device clinical studies
- S2 R1
- Good Laboratory Practice for Nonclinical Laboratory Studies
- Codevelopment of Two or More Unmarketed Investigational Drugs for Use in Combination
